In the United States, the Food and Drug Administration (FDA) classified BPC-157 as Category 2 for compounding due to adverse immune system reactions, peptide-related impurities and insufficient safety information to determine whether it would cause harm when administered to humans
Researchers now search for potential new treatments for neurological conditions, pain, and heart disease from the spider venom, cone snail toxin, and even the bat's saliva.But these findings are also a harsh reminder that most of these species are threatened by habitat loss, climate change, and human use
Potency and Stability All creams are prepared under USP guidelines, utilizing a versatile base resulting in optimal peptide stability, potency, and skin penetration
HbA1c levels typically rise within months, returning towards pre-treatment values